Pajjiż: Ingilterra
Lingwa: Ingliż
Sors: MHRA (Medicines & Healthcare Products Regulatory Agency)
Ibuprofen
Crescent Pharma Ltd
M01AE01
Ibuprofen
400mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 10010100; GTIN: 5017123291067
Package leaflet: Information for the patient Ibuprofen film coated Tablets BP 200 mg, 400 mg and 600 mg Ibuprofen Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, or pharmacist - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What Ibuprofen film coated Tablets is and what it is used for 2. What you need to know before you take Ibuprofen film coated Tablets 3. How to take Ibuprofen film coated Tablets 4. Possible side effects 5. How to store Ibuprofen film coated Tablets 6. Contents of the pack and other information 1. What Ibuprofen film coated Tablets is and what it is used for Ibuprofen belongs to a group of medicines called NSAID (non-steroidal anti- inflammatory drugs) which work by reducing pain inflammation and fever. Ibuprofen is used for the symptomatic treatment of mild to moderate pain including migraine headache period pain and/or fever. In addition, Ibuprofen is used for the symptomatic treatment of pain and inflammation in arthritic diseases (e.g. rheumatoid arthritis), degenerative arthritic conditions (e.g. osteoarthritis) and in painful swelling and inflammation aftersoft tissue injuries. 2. What you need to know before you take Ibuprofen film coated Tablets Do not take ibuprofen: • You are allergic to ibuprofen or any of the other ingredients of this medicine (listed in section 6) • If you are suffering from an ulcer or bleeding in the stomach or small intestine (duodenum) or if you have had two or more of these episodes in the past • If you have suffered from gastrointestinal bleeding or perforation related to previous use of drugs for pai Aqra d-dokument sħiħ
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ibuprofen Tablets BP 400 mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Ibuprofen BP 400 mg per tablet. Excipient with known effect: 450.89mg Sucrose. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM The product is presented in the form of a pink, sugar coated, deep convex tablet. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the relief of migraine-headaches, backache, dental pain, neuralgia and period pains as well as rheumatic and muscular pains. Ibuprofen Tablets relieves pain and reduces inflammation and temperature as well as relieving headaches and other types of pain. It also relieves cold and flu symptoms. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology For short-term use only. The lowest effective dose should be used for the shortest duration necessary to relieve symptoms (see section 4.4). Adults and the elderly: The patient should consult a doctor if symptoms persist or worsen, or if the product is required for more than 10 days. Adults, the elderly and children over 12 years: 1 tablet (400mg), up to three times a day as required. Leave at least four hours between doses and do not take more than 1200mg in any 24 hour period. _ _ _Paediatric population_ Children under 12 years: Not recommended for use in children under 12 years of age. In adolescents (age range ≥ 12 years to < 18 years): If in adolescents this medicinal product is required for more than 3 days, or if symptoms worsen a doctor should be consulted. Method of administration For oral administration. 4.3 CONTRAINDICATIONS Hypersensitivity to ibuprofen or to any of the excipients listed in section 6.1 . Patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema or urticaria) in response to ibuprofen, aspirin or other non-steroidal anti-inflammatory drugs. Active, or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding). History of gastrointestinal b Aqra d-dokument sħiħ